Latest filing published 05 Jan 2026 for Fortress Biotech, Inc..
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Malcolm Hoenlein across 5 companies, led by Fortress Biotech, Inc., DarioHealth Corp. and Water Chef Inc. We count 35 filings; the first trade dates from 29 December 2006 and the latest from 1 January 2026.
The open-market side counts 2 purchases for €286k alongside 2 sales for €70k. On balance, insiders were net buyers of €215k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 28 share grants and 1 option exercise.
The record was last updated on 5 January 2026 with a share grant in Fortress Biotech, Inc. The latest purchase dates back some time: it was published 2,246 days ago, on 1 September 2020. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 30 declarations